Australia is gain access to potentially transformative treatment for weight issues: Retatrutide. This dual compound – working on both GLP-1 and GIP receptors – demonstrates promising efficacy in global trials, indicating substantial decreases in weight. While approval remains with Australian regulators, many Australians struggling obesity could… Read More